Meta-analysis of single-arm survival studies: A distribution-free approach for estimating summary survival curves with random effects

Statistics in Medicine

Volumn 33, Issue 15, 2014, Pages 2521-2537

  Combescure, Christophe ^a   Foucher, Yohann ^b   Jackson, Daniel ^c  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b INSERM   (France)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Meta analysis; Random effects; Survival curves

Indexed keywords

ACCURACY; ARTICLE; CANCER MORTALITY; CANCER SURVIVAL; DISTRIBUTION FREE SUMMARY SURVIVAL CURVE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; LIFE EXPECTANCY; LIVER CELL CARCINOMA; MATHEMATICAL MODEL; META ANALYSIS (TOPIC); PRACTICE GUIDELINE; PROBABILITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; SURVIVAL TIME; COMPUTER SIMULATION; KIDNEY TRANSPLANTATION; LIVER TUMOR; MORTALITY; STANDARDS; STATISTICAL MODEL; SURVIVAL ANALYSIS;

CARCINOMA, HEPATOCELLULAR; COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; LIVER NEOPLASMS; META-ANALYSIS AS TOPIC; MODELS, STATISTICAL; SURVIVAL ANALYSIS;

EID: 84901952052     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.6111     Document Type: Article

References (42)

1. Earle CC, Pham B, Wells GA. An assessment of methods to combine published survival curves. Medical Decision Making 2000; 20(1):104-111. DOI: 10.1177/0272989X0002000113.
2. Hirooka T, Hamada C, Yoshimura I. A note on estimating treatment effect for time-to-event data in a literature-based meta-analysis. Methods of Information in Medicine 2009; 48(2):104-112. DOI: 10.3414/ME0535.
3. Moodie PF, Nelson NA, Koch GG. A non-parametric procedure for evaluating treatment effect in the meta-analysis of survival data. Statistics in Medicine 2004; 23(7):1075-1093. DOI: 10.1002/sim.1696.
4. Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Statistics in Medicine 1998; 17(24):2815-2834. DOI: 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8 [pii].
5. Siannis F, Barrett JK, Farewell VT, Tierney JF. One-stage parametric meta-analysis of time-to-event outcomes. Statistics in Medicine 2010; 29(29):3030-3045. DOI: 10.1002/sim.4086.
6. Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time-to-event data into meta-analysis. Trials 2007; 8: 16. DOI: 10.1186/1745-6215-8-16.
7. Tudur C, Williamson PR, Khan S, Best LY. The value of the aggregate data approach in meta-analysis with time-to-event outcomes. Journal of the Royal Statistical Society Series A-Statistics in Society 2001; 164: 357-370. DOI: 10.1111/1467-985X.00207.
8. Williamson PR, Smith CT, Hutton JL, Marson AG. Aggregate data meta-analysis with time-to-event outcomes. Statistics in Medicine 2002; 21(22):3337-3351. DOI: 10.1002/sim.1303.
9. Hernan MA. The hazards of hazard ratios. Epidemiology 2010; 21(1):13-15. DOI: 10.1097/EDE.0b013e3181c1ea43.
10. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clinical Trials 1986; 7(3):177-188. DOI: 10.1016/0197-2456(86)90046-2.
11. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002; 21(11):1539-1558. DOI: 10.1002/sim.1186.
12. Dear KB. Iterative generalized least squares for meta-analysis of survival data at multiple times. Biometrics 1994; 50(4):989-1002. DOI: 10.2307/2533438.
13. Arends LR, Hunink MG, Stijnen T. Meta-analysis of summary survival curve data. Statistics in Medicine 2008; 27(22):4381-4396. DOI: 10.1002/sim.3311.
14. Fiocco M, Putter H, van Houwelingen JC. Meta-analysis of pairs of survival curves under heterogeneity: a Poisson correlated gamma-frailty approach. Statistics in Medicine 2009; 28(30):3782-3797. DOI: 10.1002/sim.3752.
15. Fiocco M, Putter H, van Houwelingen JC. A new serially correlated gamma-frailty process for longitudinal count data. Biostatistics 2009; 10(2):245-257. DOI: 10.1093/biostatistics/kxn031.
16. Jackson D, White IR, Thompson SG. Extending DerSimonian and Laird's methodology to perform multivariate random effects meta-analyses. Statistics in Medicine 2010; 29(12):1282-1297. DOI: 10.1002/sim.3602.
17. Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Statistics in Medicine 2012; 31(29):3805-3820. DOI: 10.1002/sim.5453.
18. Cabibbo G, Enea M, Attanasio M, Bruix J, Craxi A, Camma C. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 2010; 51(4):1274-1283. DOI: 10.1002/hep.23485.
19. Ladrière M, Foucher Y, Legendre C, Kamar N, Garrigue V, Morélon E, Kessler M, Soulillou J, Giral M. The western europe cohort of kidney transplanted recipients-the DIVAT network. Clinical transplants 2010: 460-461.
20. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53: 457-481. DOI: 10.2307/2281868.
21. Pocock SJ, Clayton TC, Altman DG. Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls. Lancet 2002; 359: 1686-1689. DOI: 10.1016/S0140-6736(02)08594-X.
22. Anscombe FJ. The transformation of Poisson, binomial and negative-binomial data. Biometrika 1948; 35(3):246-254. DOI: 10.2307/2332343.
23. Brown LD, Cai TT, Zhou HH. Nonparametric regression in exponential families. The Annals of Statistics 2010; 38(4):2005-2046. DOI: 10.1214/09-AOS762.
24. Rucker G, Schwarzer G, Carpenter J, Olkin I. Why add anything to nothing? The arcsine difference as a measure of treatment effect in meta-analysis with zero cells. Statistics in Medicine 2009; 28(5):721-738. DOI: 10.1002/sim.3511.
25. Hosmer DW, Lemeshow S. Applied Survival Analysis: Regression Modeling of Time to Event Data, John Wiley and Sons Inc: New York, 1999.
26. Oelhert GW. A note on the delta method. The American Statistician 1992; 46(1):27-29.
27. Higgins JP, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (version 5.1.0 edition 2011). Section 9.6.3. http://www.cochrane-handbook.org. Accessed 12 August 2011.
28. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42(5):1208-1236. DOI: 10.1002/hep.20933.
29. Liu CL, Fan ST, Ng IO, Lo CM, Poon RT, Wong J. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. American Journal of Gastroenterology 2000; 95(1):218-222. DOI: 10.1111/j.1572-0241.2000.01688.x.
30. Kouroumalis E, Skordilis P, Thermos K, Vasilaki A, Moschandrea J, Manousos ON. Treatment of hepatocellular carcinoma with octreotide: a randomised controlled study. Gut 1998; 42(3):442-447.
31. Chung YH, Song IH, Song BC, Lee GC, Koh MS, Yoon HK, Lee YS, Sung KB, Suh DJ. Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon-alpha for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis. Cancer 2000; 88(9):1986-1991. DOI: 10.1002/(SICI)1097-0142(20000501)88:9<1986::AID-CNCR2>3.0.CO;2-I.
32. Poisot T. The digitize package: extracting numerical data from scatter-plots. The R Journal 2011; 3(1):25-26.
33. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J. Sorafenib in advanced hepatocellular carcinoma. New England Journal of Medicine 2008; 359(4):378-390. DOI: 10.1056/NEJMoa0708857.
34. Cupples LA, Gagnon DR, Ramaswamy R, D'Agostino RB. Age-adjusted survival curves with application in the Framingham study. Statistics in Medicine 1995; 14(16):1731-1744. DOI: 10.1002/sim.4780141603.
35. White IR. Multivariate random effects meta-analysis. The STATA Journal 2009; 9: 40-56.
36. Vandermeer B, Bialy L, Hooton N, Hartling L, Klassen TP, Johnston BC, Wiebe N. Meta-analysis of safety data: a comparison of exact versus asymptotic methods. Statistical Methods in Medical Research 2009; 18(4):421-432. DOI: 10.1177/0962280208092559.
37. Martin DO, Austin H. An exact method for meta-analysis of case-control and follow-up studies. Epidemiology 2000; 11(3):255-260. DOI: 10.1097/00001648-200005000-00005.
38. Tian L, Cai T, Pfeffer MA, Piankov N, Cremieux PY, Wei LJ. Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2×2 tables with all available data but without artificial continuity correction. Biostatistics 2009; 10(2):275-281. DOI: 10.1093/biostatistics/kxn034.
39. Guyot P, Ades AE, Ouwens MJ, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Medical Research Methodology 2012; 12: 9. DOI: 10.1186/1471-2288-12-9.
40. Crowther MJ, Riley RD, Staessen JA, Wang J, Gueyffier F, Lambert PC. Individual patient data meta-analysis of survival data using Poisson regression models. BMC Medical Research Methodology 2012; 12: 34. DOI: 10.1186/1471-2288-12-34.
41. Katsahian S, Latouche A, Mary JY, Chevret S, Porcher R. Practical methodology of meta-analysis of individual patient data using a survival outcome. Contemporary Clinical Trials 2008; 29(2):220-230. DOI: 10.1016/j.cct.2007.08.002.
42. Senn S. Hans van Houwelingen and the art of summing up. Biometrical Journal 2010; 52(1):85-94. DOI: 10.1002/bimj.200900074.